Literature DB >> 31230742

MicroRNAs: Turning the Tide in Testicular Cancer.

Nirmish Singla1, John T Lafin1, Aditya Bagrodia2.   

Abstract

MicroRNAs are poised to radically change the way we care for patients with germ cell tumors (GCTs) across all disease states, from diagnosis to managing chemorefractory disease. miR-371a-3p is a promising candidate biomarker that may precisely individualize GCT treatment paradigms.
Copyright © 2019 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Year:  2019        PMID： 31230742     DOI： 10.1016/j.eururo.2019.06.010

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


  8 in total

1.  The Road Ahead for Circulating microRNAs in Diagnosis and Management of Testicular Germ Cell Tumors.

Authors:  John T Lafin; Matthew J Murray; Nicholas Coleman; A Lindsay Frazier; James F Amatruda; Aditya Bagrodia
Journal:  Mol Diagn Ther       Date:  2021-04-24       Impact factor: 4.074

Review 2.  Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours.

Authors:  Kristian Almstrup; João Lobo; Nina Mørup; Gazanfer Belge; Ewa Rajpert-De Meyts; Leendert H J Looijenga; Klaus-Peter Dieckmann
Journal:  Nat Rev Urol       Date:  2020-03-10       Impact factor: 14.432

3.  The relationship of neutrophil to lymphocyte ratio with testicular cancer.

Authors:  Abdullah Ilktac; Bayram Dogan; Cevper Ersoz; Muzaffer Akcay; Habib Akbulut
Journal:  Int Braz J Urol       Date:  2020 Jan-Feb       Impact factor: 1.541

4.  Identification and Validation Model for Informative Liquid Biopsy-Based microRNA Biomarkers: Insights from Germ Cell Tumor In Vitro, In Vivo and Patient-Derived Data.

Authors:  João Lobo; Ad J M Gillis; Annette van den Berg; Lambert C J Dorssers; Gafanzer Belge; Klaus-Peter Dieckmann; Henk P Roest; Luc J W van der Laan; Jourik Gietema; Robert J Hamilton; Carmen Jerónimo; Rui Henrique; Daniela Salvatori; Leendert H J Looijenga
Journal:  Cells       Date:  2019-12-14       Impact factor: 6.600

5.  miR-483-3p, Mediated by KLF9, Functions as Tumor Suppressor in Testicular Seminoma via Targeting MMP9.

Authors:  Lei Zhang; Yashi Ruan; Zhiqiang Qin; Xian Gao; Kai Xu; Xiaokai Shi; Shenglin Gao; Shouyong Liu; Kai Zhu; Wei Wang; Li Zuo; Lifeng Zhang; Wei Zhang
Journal:  Front Oncol       Date:  2021-02-15       Impact factor: 6.244

6.  ET-1 Promotes Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Cells via the microRNA-489-3p /TWIST Axis.

Authors:  Huey-En Tzeng; Chih-Hsin Tang; Chun-Hao Tsai; Chih-Hui Chiu; Min-Huan Wu; Yun Yen
Journal:  Onco Targets Ther       Date:  2021-10-06       Impact factor: 4.147

7.  DigiMir Test: Establishing a Novel Pipeline for MiR-371a Quantification Using Droplet Digital PCR in Liquid Biopsies From Testicular Germ Cell Tumor Patients.

Authors:  José Pedro Sequeira; João Lobo; Vera Constâncio; Tiago Brito-Rocha; Carina Carvalho-Maia; Isaac Braga; Joaquina Maurício; Rui Henrique; Carmen Jerónimo
Journal:  Front Oncol       Date:  2022-06-10       Impact factor: 5.738

8.  CRIPTO and miR-371a-3p Are Serum Biomarkers of Testicular Germ Cell Tumors and Are Detected in Seminal Plasma from Azoospermic Males.

Authors:  Cassy M Spiller; João Lobo; Willem P A Boellaard; Ad J M Gillis; Josephine Bowles; Leendert H J Looijenga
Journal:  Cancers (Basel)       Date:  2020-03-23       Impact factor: 6.639
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.